HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY

被引：0

作者：

Bertamini, L. ^{[1
]}

Stefanoni, P. ^{[1
]}

Tacchetti, P. ^{[1
]}

Ledda, A. ^{[1
]}

Palmas, A. ^{[1
]}

Gentile, M. ^{[1
]}

Palmieri, S. ^{[1
]}

Annibali, O. ^{[1
]}

Musolino, C. ^{[1
]}

Burdisso, M. ^{[1
]}

Capra, A. ^{[1
]}

Rizzi, R. ^{[1
]}

Molica, S. ^{[1
]}

Cellini, C. ^{[1
]}

Monaco, F. ^{[1
]}

De Sabbata, G. ^{[1
]}

Cea, M. ^{[1
]}

Rivolti, E. ^{[1
]}

Fazio, F. ^{[1
]}

Musto, P. ^{[1
]}

Boccadoro, M. ^{[1
]}

Gay, F. ^{[1
]}

机构：

[1] European Myeloma Network, Turin, Italy

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C008

引用

页码：12 / 13

页数：2

共 50 条

[41] Incidence and Prognostic Significance of High-Risk Cytogenetically Abnormalities in Multiple Myeloma Patients in Colombia
Felipe Combariza, Juan
Orduz, Rocio
Agudelo, Claudia
Hernandez, Sonia
Maria Madera, Ana
Leon, Guillermo
Avila, Vladimir
Bautista, Leonardo
Valdes, Jaime
Camargo, Carlos
Sanchez, Victor
Mejia, Fabian
Moreno, Liliana
Ramirez, Carlos
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : 601 - 607
[42] Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
Dhakal, Binod
Sharma, Shruti
Balcioglu, Mustafa
Shchegrova, Svetlana
Malhotra, Meenakshi
Zimmermann, Bernhard
Billings, Paul R.
Harrington, Alexandra
Sethi, Himanshu
Aleshin, Alexey
Hari, Parameswaran N.
FRONTIERS IN ONCOLOGY, 2022, 12
[43] Personalized, ctDNA analysis to detect minimal residual disease and identify patients at high risk of relapse with multiple myeloma.
Dhakal, Binod
Sharma, Shruti
Shchegrova, Svetlana
Maninder, Minu
Malhotra, Meenakshi
Sethi, Himanshu
Zimmermann, Bernhard
Billings, Paul R.
Aleshin, Alexey
Hari, Parameswaran
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[44] PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS
Nishimura, Noriyuki
Ishida, Toshiaki
Yokota, Isao
Matsumoto, Kimikazu
Shichino, Hiroyuki
Kamijo, Takehiko
Takimoto, Tetsuya
Iehara, Tomoko
Tajiri, Tatsuro
PEDIATRIC BLOOD & CANCER, 2024, 71 : S13 - S13
[45] Quantitation of Minimal Residual Disease by Droplet Digital PCR in High-Risk Neuroblastoma Patients
Nishimura, Noriyuki
Ishida, Toshiaki
Thwin, Khin
Uemura, Suguru
Yamamoto, Nobuyuki
Tamura, Akihiro
Nino, Nanako
Kozaki, Aiko
Saito, Atsuro
Kishimoto, Kenji
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Takafuji, Satoru
Mori, Takeshi
Iijima, Kazumoto
PEDIATRIC BLOOD & CANCER, 2018, 65 : S38 - S39
[46] Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy
Tschautscher, Marcella A.
Jevremovic, Dragan
Rajkumar, Vincent
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Dingli, David
Hwa, Yi L.
Fonder, Amie L.
Hobbs, Miriam A.
Hayman, Suzanne R.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Lin, Yi
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Warsame, Rahma
Kyle, Robert A.
Kumar, Shaji K.
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (07) : 751 - 756
[47] Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics
Goicoechea, Ibai
Puig, Noemi
Teresa Cedena, Maria
Cordon, Lourdes
Vidriales, Maria-Belen
Burgos, Leire
Flores-Montero, Juan
Gutierrez, Norma C.
Jose Calasanz, Maria
Luisa Martin-Ramos, Maria
Lara-Astiaso, David
Vilas-Zornoza, Amaia
Alignani, Diego
Rodriguez, Idoia
Sarvide, Sarai
Garcia-Sanz, Ramon
Martinez-Lopez, Joaquin
Oriol, Albert
Rios, Rafael
Martin, Jesus
Martinez, Rafael
Sarra, Josep
Hernandez, Miguel T.
De la Rubia, Javier
Krsnik, Isabel
Maria Moraleda, Jose
Palomera, Luis
Bargay, Joan
Orfao, Alberto
Rosinol, Laura
Mateos, Maria-Victoria
Jose Lahuerta, Juan
Blade, Joan
San-Miguel, Jesus F.
Paiva, Bruno
BLOOD, 2018, 132
[48] Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients.
Mailankody, Sham
Korde, Neha
Roschewski, Mark J.
Christofferson, Austin
Boateng, Martin
Zhang, Yong
Manasanch, Elisabet Esteve
Kazandjian, Dickran Gano
Kwok, Mary
Bhutani, Manisha
Tageja, Nishant
Zingone, Adriana
Costello, Rene
Lamy, Laurence
Hultcrantz, Malin
Papaemmanuil, Elli
Stetler-Stevenson, Maryalice
Figg, William Douglas
Keats, Jonathan J.
Landgren, Ola
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[49] High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
Bertamini, Luca
Oliva, Stefania
Rota-Scalabrini, Delia
Paris, Laura
More, Sonia
Corradini, Paolo
Ledda, Antonio
Gentile, Massimo
De Sabbata, Giovanni
Pietrantuono, Giuseppe
Pascarella, Anna
Tosi, Patrizia
Curci, Paola
Gilestro, Milena
Capra, Andrea
Galieni, Piero
Pisani, Francesco
Annibali, Ombretta
Monaco, Federico
Liberati, Anna Marina
Palmieri, Salvatore
Luppi, Mario
Zambello, Renato
Fazio, Francesca
Belotti, Angelo
Tacchetti, Paola
Musto, Pellegrino
Boccadoro, Mario
Gay, Francesca
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) : 3120 - +
[50] Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma
Ningning Wang
Nahom Tesfaluul
Jia Li
Xiaojuan Gao
Shuai Liu
Baohong Yue
Annals of Hematology, 2019, 98 : 2769 - 2780

← 1 2 3 4 5 →